<bill session="115" type="h" number="5333" updated="2023-01-11T13:40:11Z">
  <state datetime="2018-07-16T18:24:53-04:00">PASS_OVER:HOUSE</state>
  <status>
    <unknown datetime="2018-07-16T18:24:53-04:00"/>
  </status>
  <introduced datetime="2018-03-19"/>
  <titles>
    <title type="display">Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018</title>
    <title type="official" as="introduced">To amend the Federal Food, Drug, and Cosmetic Act to clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved new drug application, and for other purposes.</title>
    <title type="short" as="reported to house">Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018</title>
    <title type="short" as="reported to house" partial="1">Over-the-Counter Monograph User Fee Act of 2018</title>
    <title type="short" as="passed house">Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018</title>
    <title type="short" as="passed house" partial="1">Over-the-Counter Monograph User Fee Act of 2018</title>
    <title type="short" as="introduced">Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018</title>
    <title type="short" as="introduced" partial="1">Over-the-Counter Monograph User Fee Act of 2018</title>
  </titles>
  <sponsor bioguide_id="L000566"/>
  <cosponsors>
    <cosponsor bioguide_id="B001248" joined="2018-03-19"/>
    <cosponsor bioguide_id="D000197" joined="2018-03-19"/>
    <cosponsor bioguide_id="D000624" joined="2018-03-19"/>
    <cosponsor bioguide_id="F000459" joined="2018-05-18"/>
    <cosponsor bioguide_id="G000410" joined="2018-03-19"/>
    <cosponsor bioguide_id="G000558" joined="2018-03-19"/>
    <cosponsor bioguide_id="M001163" joined="2018-05-15"/>
    <cosponsor bioguide_id="S001180" joined="2018-07-10"/>
  </cosponsors>
  <actions>
    <action datetime="2018-03-19">
      <text>Introduced in House</text>
    </action>
    <action datetime="2018-03-19" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2018-03-23">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2018-05-09">
      <text>Committee Consideration and Mark-up Session Held.</text>
    </action>
    <action datetime="2018-05-09" state="REPORTED">
      <text>Ordered to be Reported (Amended) by Voice Vote.</text>
    </action>
    <action datetime="2018-07-16">
      <text>Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-827.</text>
    </action>
    <calendar datetime="2018-07-16" calendar="Union" number="640">
      <text>Placed on the Union Calendar, Calendar No. 640.</text>
    </calendar>
    <action datetime="2018-07-16T18:06:16-04:00">
      <text>Mr. Latta moved to suspend the rules and pass the bill, as amended.</text>
    </action>
    <action datetime="2018-07-16T18:06:25-04:00">
      <text>Considered under suspension of the rules.</text>
      <reference ref="CR H6227-6237" label="consideration"/>
    </action>
    <action datetime="2018-07-16T18:06:26-04:00">
      <text>DEBATE - The House proceeded with forty minutes of debate on H.R. 5333.</text>
    </action>
    <vote how="by voice vote" type="vote" datetime="2018-07-16T18:24:53-04:00" where="h" result="pass" state="PASS_OVER:HOUSE">
      <text>On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.</text>
      <reference ref="CR H6227-6235" label="text"/>
    </vote>
    <action datetime="2018-07-16T18:24:54-04:00">
      <text>Motion to reconsider laid on the table Agreed to without objection.</text>
    </action>
    <calendar datetime="2018-07-17" calendar="Senate Legislative" under="General Orders" number="518">
      <text>Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 518.</text>
    </calendar>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Reporting, Markup, Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="115" type="s" number="2315" relation="unknown"/>
    <bill session="115" type="h" number="7328" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Government studies and investigations"/>
    <term name="Inflation and prices"/>
    <term name="Prescription drugs"/>
    <term name="User charges and fees"/>
  </subjects>
  <amendments/>
  <summary date="2019-08-20T16:59:12Z" status="Introduced in House">Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018

This bill amends the Federal Food, Drug, and Cosmetic Act to substantially revise how over-the-counter (OTC)drugs are approved.</summary>
  <committee-reports>
    <report>H. Rept. 115-827</report>
  </committee-reports>
</bill>
